Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
18 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04543617 | A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy(SKYSCRAPER-07) | completed | Phase 3 | 760 | Hoffmann-La RocheINDUSTRY | 28 | Sep 14, 2026 | clinicaltrials |
| NCT03371017 | A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer(IMpassion132) | completed | Phase 3 | 595 | Hoffmann-La Roche |
| 28 |
| Nov 12, 2025 |
| clinicaltrials |
| NCT02406092 | Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A | completed | Phase 3 | 139 | Hoffmann-La RocheINDUSTRY | 3 | Nov 21, 2024 | clinicaltrials |
| NCT03125902 | A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)(IMpassion131) | completed | Phase 3 | 653 | Hoffmann-La RocheINDUSTRY | 24 | Mar 26, 2024 | clinicaltrials |
| NCT03447132 | Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant(SAFIA) | completed | Phase 3 | 354 | International Cancer Research Group, United Arab EmiratesOTHER | 8 | Mar 10, 2023 | clinicaltrials |
| NCT01566721 | A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(SafeHER) | completed | Phase 3 | 2,577 | Hoffmann-La RocheINDUSTRY | 59 | Apr 27, 2021 | clinicaltrials |
| NCT01572038 | A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer(PERUSE) | completed | Phase 3 | 1,436 | Hoffmann-La RocheINDUSTRY | 39 | Sep 25, 2020 | clinicaltrials |
| NCT03176238 | Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer(EVEREXES) | completed | Phase 3 | 235 | Novartis PharmaceuticalsINDUSTRY | 13 | Apr 7, 2020 | clinicaltrials |
| NCT00828386 | Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers(NPC2006) | terminated | Phase 3 | 83 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 4 | Jan 18, 2019 | clinicaltrials |
| NCT00722137 | Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma | completed | Phase 3 | 487 | Millennium Pharmaceuticals, Inc.INDUSTRY | 29 | Jul 12, 2018 | clinicaltrials |
| NCT00293540 | Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer | completed | Phase 3 | 249 | International Breast Cancer Research FoundationOTHER | 10 | Jul 27, 2016 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT00201851 | Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | completed | Phase 3 | 740 | International Breast Cancer Research FoundationOTHER | 3 | Apr 29, 2015 | clinicaltrials |
| NCT00864331 | Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy | completed | Phase 3 | 251 | International Atomic Energy AgencyOTHER_GOV | 13 | Aug 7, 2013 | clinicaltrials |
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 3 | 3,300 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 29 | Mar 28, 2013 | clinicaltrials |
| NCT01452672 | Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer | unknown | Phase 3 | 600 | International Atomic Energy AgencyOTHER_GOV | 8 | Oct 17, 2011 | clinicaltrials |
| NCT00122772 | CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy | completed | Phase 3 | 601 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 14, 2011 | clinicaltrials |
Data updated 15 days agoSource updated unknownsource: clinicaltrials